Skip header and navigation

7 records – page 1 of 1.

Cancer Chemoprevention. Vol. 2, Strategies for Cancer Chemoprevention

https://libcat.nshealth.ca/en/permalink/provcat30010
edited by Gary J. Kelloff, Ernest T. Hawk, Caroline C. Sigman. --Totowa, NJ: Humana Press , c2005.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Kelloff, Gary J
Other Authors
Hawk, Ernest T
Sigman, Caroline C
Responsibility
edited by Gary J. Kelloff, Ernest T. Hawk, Caroline C. Sigman
Place of Publication
Totowa, NJ
Publisher
Humana Press
Date of Publication
c2005
Series Title
Cancer drug discovery and development
ISBN
9781592597680
Subjects (MeSH)
Anticarcinogenic Agents - therapeutic use
Chemoprevention - methods
Neoplasms - prevention & control
Subjects (LCSH)
Oncology
Pharmacy
Format
e-Book
Location
Online
Less detail

Cancer Prevention

https://libcat.nshealth.ca/en/permalink/provcat28658
edited by Hans-Jörg Senn, Ursula Kapp. --Berlin, Heidelberg: Springer-Verlag , c2007.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Senn, Hans-Jörg
Other Authors
International Conference on Cancer Prevention (4th : 2006 : University of St. Gallen)
Other Authors
Kapp, Ursula
Responsibility
edited by Hans-Jörg Senn, Ursula Kapp
Place of Publication
Berlin, Heidelberg
Publisher
Springer-Verlag
Date of Publication
c2007
Series Vol.
174
Series Title
Recent results in cancer research
ISBN
9783540376965
Subjects (MeSH)
Chemoprevention - Congresses
Neoplasms - prevention & control
Subjects (LCSH)
Oncology
Format
e-Book
Location
Online
Less detail

Cancer Prevention II

https://libcat.nshealth.ca/en/permalink/provcat29296
edited by Hans-Jörg Senn, Ursula Kapp, Florian Otto. --Berlin, Heidelberg: Springer , c2009.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Senn, Hans-Jörg
Other Authors
International Conference on Cancer Prevention (5th : 2008 : University of St. Gallen)
Other Authors
Kapp, Ursula
Otto, Florian
Responsibility
edited by Hans-Jörg Senn, Ursula Kapp, Florian Otto
Place of Publication
Berlin, Heidelberg
Publisher
Springer
Date of Publication
c2009
Series Vol.
181
Series Title
Recent results in cancer research
ISBN
9783540692973
Subjects (MeSH)
Chemoprevention - Congresses
Neoplasms - prevention & control - Congresses
Subjects (LCSH)
Oncology
Format
e-Book
Location
Online
Less detail

Clinical Cancer Prevention

https://libcat.nshealth.ca/en/permalink/provcat29112
edited by Hans-Jörg Senn, Florian Otto. --Berlin, Heidelberg: Springer-Verlag , c2011.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Senn, Hans-Jörg
Other Authors
International Conference on Clinical Cancer Prevention (6th : 2010 : St. Gallen, Switzerland)
Other Authors
Otto, Florian
Responsibility
edited by Hans-Jörg Senn, Florian Otto
Place of Publication
Berlin, Heidelberg
Publisher
Springer-Verlag
Date of Publication
c2011
Series Vol.
188
Series Title
Recent results in cancer research
ISBN
9783642108587
Subjects (MeSH)
Chemoprevention - Congresses
Neoplasms - prevention & control - Congresses
Subjects (LCSH)
Oncology
Format
e-Book
Location
Online
Less detail

Prospects for chemoprevention of colorectal neoplasia : emerging role of anti-inflammatory drugs

https://libcat.nshealth.ca/en/permalink/provcat32505
Andrew T. Chan, Elmar Detering, editors. --Berlin, Heidelberg: Springer , c2013.
Available Online
View e-Book
Location
Online
The prevention of colorectal cancer is a subject of increasing medical importance, and there have been a number of promising recent developments. This book examines in detail important aspects of the current status and future prospects for chemoprevention of colorectal tumors. Research into the mechanisms that lead from early colorectal adenoma to colorectal cancer is discussed. The role and modes of action of available drugs such as celecoxib and sulindac are described, and recent data from a…
Available Online
View e-Book
Other Authors
Chan, Andrew T
Detering, Elmar
Responsibility
Andrew T. Chan, Elmar Detering, editors
Place of Publication
Berlin, Heidelberg
Publisher
Springer
Date of Publication
c2013
Physical Description
1 online resource (viii, 183 p. : 29 ill., 18 ill. in color)
Series Vol.
191
Series Title
Recent results in cancer research
ISBN
9783642303319
Subjects (MeSH)
Anti-Inflammatory Agents - therapeutic use
Chemoprevention
Colorectal Neoplasms - prevention & control
Precancerous Conditions - drug therapy
Subjects (LCSH)
Internal medicine
Cardiology
Gastroenterology
Oncology
Colon (Anatomy) - Surgery
Abstract
The prevention of colorectal cancer is a subject of increasing medical importance, and there have been a number of promising recent developments. This book examines in detail important aspects of the current status and future prospects for chemoprevention of colorectal tumors. Research into the mechanisms that lead from early colorectal adenoma to colorectal cancer is discussed. The role and modes of action of available drugs such as celecoxib and sulindac are described, and recent data from aspirin trials are analyzed. In addition, the possible impact of nutritional agents with anti-inflammatory properties is considered, and strategies applicable in those with a high level of genetic risk are evaluated. An important feature of the book is its holistic perspective, making it relevant for gastroenterologists, internists, general practitioners, oncologists, colorectal and gastroenterological surgeons, and public health practitioners.
Contents
What is chemoprevention today?- Mechanistic aspects in tumor development and progression of colorectal adenoma and carcinoma -- Mode of action of aspirin as a chemopreventive agent -- Coxibs: pharmacology, toxicity and efficacy in cancer clinical trials -- COX-2 active agents in chemoprevention (includes aspirin, coxibs, and DFMO) -- New potential developments in aspirin/NSAID derivatives -- Aspirin in CRC chemoprevention in the context of other chronic diseases -- Nutritional agents with anti-inflammatory properties in chemoprevention of colorectal adenoma and carcinoma -- Genetic risks for CRC and hereditary forms of CRC. Strategies for prevention in high risk population -- References.
Format
e-Book
Location
Online
Less detail

Prostate cancer prevention

https://libcat.nshealth.ca/en/permalink/provcat33417
Jack Cuzick, Mangesh A. Thorat, editors. --Heidelberg: Springer , c2014.
Available Online
View e-Book
Location
Online
Prostate cancer is by far the most common cancer in men and the second leading cause of death due to cancer. It comprises a mixed group of tumours displaying varying clinical behaviour: while some have a very aggressive course, others are rather indolent. Prevention of prostate cancer and discrimination between aggressive and indolent forms are important clinical goals, and the acquisition of significant new evidence on means of achieving these aims makes this book particularly timely. A wide r…
Available Online
View e-Book
Other Authors
Cuzick, J
Thorat, Mangesh A
Responsibility
Jack Cuzick, Mangesh A. Thorat, editors
Place of Publication
Heidelberg
Publisher
Springer
Date of Publication
c2014
Physical Description
1 online resource (viii, 169 pages)
Series Vol.
v. 202
Series Title
Recent results in cancer research
ISBN
9783642451959 (electronic bk.)
9783642451942
Subjects (MeSH)
Prostatic Neoplasms - prevention & control
Anticarcinogenic Agents
Chemoprevention
Early Detection of Cancer
Risk Factors
Subjects (LCSH)
Prostate - Cancer - Prevention
Prostatic Neoplasms - prevention & control
Risk Assessment
Biological Markers
Life Style
Risk Factors
Diet
Chemoprevention
Oncology
Abstract
Prostate cancer is by far the most common cancer in men and the second leading cause of death due to cancer. It comprises a mixed group of tumours displaying varying clinical behaviour: while some have a very aggressive course, others are rather indolent. Prevention of prostate cancer and discrimination between aggressive and indolent forms are important clinical goals, and the acquisition of significant new evidence on means of achieving these aims makes this book particularly timely. A wide range of topics are covered by leading authorities in the field. The biology and natural history of prostate cancer are reviewed, and the role of lifestyle and dietary factors, assessed. Detailed attention is paid to risk prediction biomarkers and to the role of novel high-throughput nucleic acid-based technologies in improving risk prediction and thereby allowing tailored approaches to cancer prevention. Potential means of chemoprevention of prostate cancer are also reviewed in depth, covering the very positive new data on the impact of aspirin as well as evidence regarding 5-reductase inhibitors, DFMO, and lycopene. Guidance is provided on the differentiation of aggressive from indolent disease, and the policy and research implications of recent findings are examined. This book will be of interest to both clinicians and researchers.
Contents
The biology and natural history of prostate cancer: a short introduction -- Germline genetic variants associated with prostate cancer and potential relevance to clinical practice -- Lifestyle and dietary factors in prostate cancer prevention -- Nutrition, hormones and prostate cancer risk: results from the European prospective investigation into cancer and nutrition -- Screening for prostate cancer: current status of ERSPC and screening-related issues -- Update of the prostate, lung, colorectal, and ovarian cancer screening trial -- ERSPC, PLCO studies and critique of Cochrane review 2013 -- Screening for prostate cancer: reflecting on the quality of evidence from the ERSPC and PLCO studies -- Phase III prostate cancer chemoprevention trials -- Risk adapted chemoprevention for prostate cancer: an option? -- Aspirin and prostate cancer prevention -- Chemoprevention of prostate cancer by isoflavonoids -- Lycopene for the prevention and treatment of prostate disease -- Chemoprevention of prostate cancer with the polyamine -- Synthesis inhibitor difluoromethylornithine -- Prostate cancer prevention: agent development strategies -- Prognostic value of a cell cycle progression score for men with prostate cancer -- Distinguishing indolent from aggressive prostate cancer -- Management of low risk and low PSA prostate cancer: long term results from the prostate cancer intervention versus observation trial.
Format
e-Book
Location
Online
Less detail

Tumor Prevention and Genetics III

https://libcat.nshealth.ca/en/permalink/provcat29982
edited by Hans-Jörg Senn, Rudolf Morant. --Berlin, Heidelberg: Springer-Verlag , c2005.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Senn, Hans-Jörg
Other Authors
International Conference on Controversies in Tumor Prevention and Genetics (3rd : 2004 : Saint Gall, Switzerland)
Other Authors
Morant, Rudolf
Responsibility
edited by Hans-Jörg Senn, Rudolf Morant
Place of Publication
Berlin, Heidelberg
Publisher
Springer-Verlag
Date of Publication
c2005
Series Vol.
166
Series Title
Recent results in cancer research
ISBN
9783540269809
Subjects (MeSH)
Chemoprevention
Neoplasms - genetics
Neoplasms - prevention & control
Subjects (LCSH)
Genetics
Oncology
Format
e-Book
Location
Online
Less detail

7 records – page 1 of 1.